Phillips gail lewis (26 risultati)

Condizione: New.

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Condizione: New. In English.

Condizione: New. In English.

Hardback. Condizione: New. 2013 ed. This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.…

Condizione: New. This volume collets leading research on antibody-drug conjugates and immunotoxins. It examines all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies. Editor(s): Phillips, Gail Lewis; Teicher, Beverly A. Series: Cancer Drug Discovery and Development. Num Pages: 388 pages, biography. BIC Classification: MBGR; MJCL; MJCM. Category: (P) Professional & Vocational. Dimension: 239 x 163 x 28. Weight in Grams: 758. . 2012. 2013th Edition. hardcover. . . . . …

Taschenbuch. Condizione: Neu. Antibody-Drug Conjugates and Immunotoxins | From Pre-Clinical Development to Therapeutic Applications | Gail Lewis Phillips | Taschenbuch | Cancer Drug Discovery and Development | x | Englisch | 2015 | Springer | EAN 9781489997005 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.…

Condizione: New. pp. 378.

Hardcover. Condizione: Brand New. 1st edition. 375 pages. 9.25x6.50x1.00 inches. In Stock.

Condizione: New. This volume collets leading research on antibody-drug conjugates and immunotoxins. It examines all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies. Editor(s): Phillips, Gail Lewis; Teicher, Beverly A. Series: Cancer Drug Discovery and Development. Num Pages: 388 pages, biography. BIC Classification: MBGR; MJCL; MJCM. Category: (P) Professional & Vocational. Dimension: 239 x 163 x 28. Weight in Grams: 758. . 2012. 2013th Edition. hardcover. . . . . Books ship from the US and Ireland. …

Hardback. Condizione: New. 2013 ed. This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.…

Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condizione: As New. Unread book in perfect condition.

Condizione: new. Questo è un articolo print on demand.

Condizione: new. Questo è un articolo print on demand.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies. 388 pp. Englisch.…

Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The concept of delivering magic bullets to treat diseases was first proposed by Paul Erlich in the early 1900 s. The realization of this concept for the treatment of cancer occurred in the late 1990 s with the approval of monoclonal antibody therapies. The use of monoclonal antibodies conjugated (linked) to potent cytotoxic agents (antibody-drug conjugates, ADCs) for specifically delivering cytotoxics to cancer cells was an obvious extension of antibody-based therapy. ADCs have been under intense investigation for several decades; progress, however, has been limited due to toxicity or lack of improved efficacy compared to unconjugated cytotoxics. More recently, linker technology and target selection have advanced such that several ADCs and immunotoxins are undergoing clinical testing or are approved for use. This important volume gives the latest and most comprehensive information on the topic, describing different types of ADCs and immunotoxins for both hematologic and solid malignancies. Finally, the volume highlights the promise that this technology holds for diverse types of human cancer. 388 pp. Englisch.…

Kartoniert / Broschiert. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Features up-to-date research Provides an exhaustive review of anti-body drug conjugate and immunotoxin targets Explores new technologies for site-specific conjugationThis volume gathers the leading research on antibody-drug conjugat.…

Gebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Features up-to-date research Provides an exhaustive review of anti-body drug conjugate and immunotoxin targets Explores new technologies for site-specific conjugationThis volume gathers the leading research on antibody-drug conjugat.…

Buch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The concept of delivering magic bullets to treat diseases was first proposed by Paul Erlich in the early 1900 s. The realization of this concept for the treatment of cancer occurred in the late 1990 s with the approval of monoclonal antibody therapies. The use of monoclonal antibodies conjugated (linked) to potent cytotoxic agents (antibody-drug conjugates, ADCs) for specifically delivering cytotoxics to cancer cells was an obvious extension of antibody-based therapy. ADCs have been under intense investigation for several decades; progress, however, has been limited due to toxicity or lack of improved efficacy compared to unconjugated cytotoxics. More recently, linker technology and target selection have advanced such that several ADCs and immunotoxins are undergoing clinical testing or are approved for use. This important volume gives the latest and most comprehensive information on the topic, describing different types of ADCs and immunotoxins for both hematologic and solid malignancies. Finally, the volume highlights the promise that this technology holds for diverse types of human cancer.…

Buch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 388 pp. Englisch.…

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 388 pp. Englisch.…

Condizione: New. Print on Demand pp. 378.

Condizione: New. PRINT ON DEMAND pp. 378.